JP2024513912A5 - - Google Patents

Info

Publication number
JP2024513912A5
JP2024513912A5 JP2023561664A JP2023561664A JP2024513912A5 JP 2024513912 A5 JP2024513912 A5 JP 2024513912A5 JP 2023561664 A JP2023561664 A JP 2023561664A JP 2023561664 A JP2023561664 A JP 2023561664A JP 2024513912 A5 JP2024513912 A5 JP 2024513912A5
Authority
JP
Japan
Prior art keywords
cells
inhibitor
contact
culture
signaling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/023797 external-priority patent/WO2022216911A1/en
Publication of JP2024513912A publication Critical patent/JP2024513912A/ja
Publication of JP2024513912A5 publication Critical patent/JP2024513912A5/ja
Pending legal-status Critical Current

Links

JP2023561664A 2021-04-07 2022-04-07 ドーパミン作動性前駆細胞（ｐｒｅｃｕｒｓｏｒ ｃｅｌｌ）及び使用方法 Pending JP2024513912A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163171837P 2021-04-07 2021-04-07
US63/171,837 2021-04-07
US202163275691P 2021-11-04 2021-11-04
US63/275,691 2021-11-04
PCT/US2022/023797 WO2022216911A1 (en) 2021-04-07 2022-04-07 Dopaminergic precursor cells and methods of use

Publications (2)

Publication Number Publication Date
JP2024513912A JP2024513912A (ja) 2024-03-27
JP2024513912A5 true JP2024513912A5 (https=) 2025-04-14

Family

ID=81392616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561664A Pending JP2024513912A (ja) 2021-04-07 2022-04-07 ドーパミン作動性前駆細胞（ｐｒｅｃｕｒｓｏｒ ｃｅｌｌ）及び使用方法

Country Status (7)

Country Link
US (1) US20240219375A1 (https=)
EP (1) EP4319876A1 (https=)
JP (1) JP2024513912A (https=)
KR (1) KR20230165846A (https=)
AU (1) AU2022256048A1 (https=)
CA (1) CA3213988A1 (https=)
WO (1) WO2022216911A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118530944A (zh) * 2023-02-21 2024-08-23 士泽生物医药（苏州）有限公司 一种诱导干细胞分化为多巴胺能神经前体细胞和/或多巴胺神经元的试剂盒及其应用
US12565639B2 (en) 2023-06-13 2026-03-03 Aspen Neuroscience, Inc. Methods for differentiating dopaminergic neurons from stem cells
CN119269789B (zh) * 2023-07-06 2026-04-24 深圳华大生命科学研究院 多巴胺能神经元前体细胞的标志物及其应用
WO2025049336A2 (en) * 2023-08-25 2025-03-06 Bluerock Therapeutics Lp Methods and compositions of dopaminergic cells for treating parkinson's disease
US20250157580A1 (en) * 2023-11-13 2025-05-15 Aspen Neuroscience, Inc. Methods of predicting dopamine production capability of differentiated neuronal cells

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
WO2001088100A1 (en) 2000-05-16 2001-11-22 Kyowa Hakko Kogyo Co., Ltd. Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
UY27224A1 (es) 2001-03-23 2002-10-31 Bayer Corp Inhibidores de la rho-quinasa
PE20020958A1 (es) 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
US20030211603A1 (en) 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
JP4505228B2 (ja) 2002-01-10 2010-07-21 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト Ｒｈｏ−キナーゼ阻害剤
EP1470121B1 (en) 2002-01-23 2012-07-11 Bayer HealthCare LLC Pyrimidine derivatives as rho-kinase inhibitors
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
ES2273047T3 (es) 2002-10-28 2007-05-01 Bayer Healthcare Ag Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
WO2005080554A1 (ja) 2004-02-23 2005-09-01 Kyoto University 胚性幹細胞の分化調節方法
WO2005123902A1 (ja) 2004-06-18 2005-12-29 Riken 無血清浮遊培養による胚性幹細胞の神経分化誘導法
AU2005282414C1 (en) 2004-09-08 2011-04-07 Wisconsin Alumni Research Foundation Culturing human embryonic stem cells
US20070116680A1 (en) 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
WO2008089351A1 (en) 2007-01-17 2008-07-24 Wisconsin Alumni Research Foundation Improved culture of stem cells
EP3279314A1 (en) 2008-06-04 2018-02-07 Cellular Dynamics International, Inc. Methods for the production of ips cells using non-viral approach
ES2633935T3 (es) 2008-12-05 2017-09-26 Inserm - Institut National De La Santé Et De La Recherche Médicale Método y medio para la diferenciación neural de células pluripotentes
WO2010141801A2 (en) 2009-06-05 2010-12-09 Cellular Dynamics International, Inc. Reprogramming t cells and hematophietic cells
DK2694644T3 (en) 2011-03-30 2018-04-16 Cellular Dynamics Int Inc Priming of pluripotent stem cells for neural differentiation
EP3693455A1 (en) 2011-11-04 2020-08-12 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (da) neurons for engraftment
EP3031908B1 (en) 2013-08-06 2018-12-05 Takeda Pharmaceutical Company Limited Method for producing dopaminergic neurons
ES2939807T3 (es) 2014-03-21 2023-04-27 Fujifilm Cellular Dynamics Inc Producción de neuronas dopaminérgicas del mesencéfalo y métodos para su utilización
AU2016270793B2 (en) * 2015-06-01 2022-06-09 Memorial Sloan-Kettering Cancer Center Methods of in vitro differentiation of midbrain dopamine (MDA) neurons
KR102625865B1 (ko) * 2016-08-16 2024-01-16 후지필름 셀룰러 다이내믹스, 인코포레이티드 만능 세포를 분화시키는 방법

Similar Documents

Publication Publication Date Title
JP2024513912A5 (https=)
JP2022078245A5 (https=)
Francis et al. Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning
Montzka et al. Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression
KR102296446B1 (ko) 인간 만능 줄기세포로부터 제작된 3d 오가노이드를 해체하여 세포를 다량 확보하는 분화방법
Qin et al. Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors
Nakayama et al. Efficient production of neural stem cells and neurons from embryonic stem cells
WO2015131797A1 (zh) 诱导体细胞转分化为神经干细胞的方法及其应用
CN105392881B (zh) 体细胞基于小分子转化为神经嵴细胞
CN113684182B (zh) TGF-β抑制剂在诱导神经干细胞及类器官形成中的应用
CN105039258A (zh) 将非神经元细胞重编程为神经元样细胞的方法和组合物
WO2022037570A1 (zh) 一种神经类细胞的扩增培养基及培养方法
CN108103021A (zh) 一种新型人源诱导型神经干细胞的制备方法及其应用
CN114736864B (zh) 一种神经干细胞诱导分化培养基及诱导分化方法
Garbayo et al. Neuroprotective properties of marrow‐isolated adult multilineage‐inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers
Wang et al. Chemical conversion of mouse fibroblasts into functional dopaminergic neurons
CN115151633A (zh) 多潜能干细胞衍生的多巴胺能亚型神经元祖细胞的体外扩增
Aguilera-Castrejon et al. Improved proliferative capacity of NP-like cells derived from human mesenchymal stromal cells and neuronal transdifferentiation by small molecules
US20220333071A1 (en) Methods of making, expanding and purifying midbrain dopaminergic progenitor cells
Yun et al. Generation of anterior hindbrain-specific, glial-restricted progenitor-like cells from human pluripotent stem cells
JP7587584B2 (ja) ヒト多能性幹細胞から調製された３ｄオルガノイドをチョッピングして大量の細胞を獲得する分化方法
CN117448271B (zh) 一种诱导多能干细胞分化为中脑多巴胺能神经前体细胞的方法
Jiang et al. Structural and functional improvement of injured brain after severe acute carbon monoxide poisoning by stem cell–based therapy in rats
WO2016078063A1 (zh) 持续维持运动神经元前驱细胞生长的方法及医药组合物
CN120536366B (zh) 一种构建内耳前体细胞及内耳类器官的方法和应用